| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 24 |
| 1 | METFORMIN | 19 |
| 2 | LEVOTHYROXINE SODIUM | 16 |
| 3 | METFORMIN ER 500 MG | 16 |
| 4 | METFORMIN ER 750 MG | 16 |
| 5 | EMPAGLIFLOZIN | 15 |
| 6 | DAPAGLIFLOZIN | 14 |
| 7 | OCRELIZUMAB | 14 |
| 8 | ETONOGESTREL AND ETHINYL ESTRADIOL | 12 |
| 9 | FLUCONAZOLE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0122 |
| 1 | DALBAVANCIN HYDROCHLORIDE | 1 | 0.0021 |
| 2 | IMIPRAMINE HYDROCHLORIDE | 1 | 0.0018 |
| 3 | FOSFOMYCIN TROMETHAMINE | 1 | 0.0016 |
| 4 | HYDROCORTISONE VALERATE | 1 | 0.0016 |
| 5 | ALOSETRON HYDROCHLORIDE | 1 | 0.0012 |
| 6 | 12%AZELAIC ACID | 1 | 0.0012 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 9 | 0.0011 |
| 8 | ESTROGEN | 3 | 0.0010 |
| 9 | EMPAGLIFLOZIN AND LINAGLIPTIN | 2 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 40 |
| 1 | Corticosteroid [EPC] | 34 |
| 2 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 28 |
| 3 | Estrogen [EPC] | 26 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 5 | Progestin-containing Intrauterine System [EPC] | 24 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 18 |
| 7 | Azole Antifungal [EPC] | 17 |
| 8 | Benzodiazepine [EPC] | 14 |
| 9 | Aromatase Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Agonist/Antagonist [EPC] | 2 | 0.0008 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Penem Antibacterial [EPC] | 10 | 0.0003 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 28 | 0.0003 |
| 4 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 5 | beta3-Adrenergic Agonist [EPC] | 11 | 0.0002 |
| 6 | Antiseptic [EPC] | 1 | 0.0002 |
| 7 | Aminoglycoside Antibacterial [EPC] | 9 | 0.0002 |
| 8 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 9 | Copper-containing Intrauterine Device [EPC] | 7 | 0.0001 |